PRIA Logo™
119-s-5502119th CongressWALLET

Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act

Sponsored By: Senator Hassan, Margaret Wood [D-NH]

Introduced

Summary

This bill would explicitly treat biotechnology and biomanufacturing infrastructure as critical infrastructure. It would amend the Homeland Security Act so the Cybersecurity and Infrastructure Security Agency (CISA) serves as the default coordinator and protector when no Sector-Specific Agency exists.

Show full summary
  • Owners and operators of biotech and biomanufacturing facilities would become formal stakeholders for federal risk analyses, outreach, and protective measures.
  • CISA would be required to designate staff to provide analyses, expertise, and technical assistance and to carry out outreach and to convene relevant sector agencies when no SSA is designated.
  • The bill would require coordination with Information Sharing and Analysis Organizations (ISACs) such as BIO-ISAC and H-ISAC, a CISA work plan within 45 days, and updates to strategic plans by Sept 30, 2027.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

More protection for biotech businesses

If enacted, the bill would explicitly treat biotechnology and biomanufacturing as critical infrastructure and name facility owners and operators as stakeholders. It would require CISA to assign staff to provide analysis, technical assistance, outreach, and to coordinate risk and vulnerability assessments when no Sector-Specific Agency exists. CISA would have to coordinate those assessments with industry ISACs such as BIO-ISAC and H-ISAC. The Director would need to send a work plan to the House Committee on Homeland Security and the Senate Committee on Homeland Security and Governmental Affairs within 45 days, report on implementation within one year, update strategic plans by September 30, 2027, and report within two years whether any biotech areas remain unprotected.

Sponsors & CoSponsors

Sponsor

Hassan, Margaret Wood [D-NH]

NH • D

Cosponsors

  • Sen. Young, Todd [R-IN]

    IN • R

    Sponsored 9/24/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation